Dr. Tolaney Discusses Patient Selection For Platinum-Based Therapy In Tnbc

Dr. Tolaney Discusses Patient Selection for Platinum-Based Therapy in TNBC

Targeted Oncology

Dr. Tolaney on Platinum-Based Therapy in Neoadjuvant Setting of TNBC

Role of Neoadjuvant Platinum-Based Therapy for TNBC

Dr. Sara M. Tolaney on Neoadjuvant Treatment Considerations for TNBC

Dr. Tolaney on Pembrolizumab Plus Eribulin in TNBC

Sara M. Tolaney on Neoadjuvant Treatment Considerations for Triple-Negative Breast Cancer

Dr. Tolaney on Deescalating Therapy in Stage I HER2+ Breast Cancer

Dr. Tolaney on Novel Approaches in Treating HER2-Positive Breast Cancer

Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer

Research To Practice

Dr. Tolaney on Trials Investigating Cabozantinib in Breast Cancer

Dr Tolaney on Data With Checkpoint Inhibitor Combinations in Metastatic TNBC

Dr. Tolaney Discusses the Role of Chemotherapy in HER2+ Breast Cancer

Dr. Tolaney on the Neoadjuvant Therapy for HER2-Positive Breast Cancer

Test to identity which breast cancer patients will respond to platinum-based chemotherapy

Dr. Tolaney on Abemaciclib Plus Pembrolizumab for HR+, HER2- Breast Cancer

A Study Investigating Pembrolizumab in Combination With Eribulin in TNBC

Targeted Oncology

Dr. Tolaney Discusses Unmet Needs in ER+ Breast Cancer

Expert Perspectives in the Management of Triple-Negative Breast Cancer With Sara Tolaney, MD, MPH

Oncology Data Advisor

SABCS 2016 - Sara Tolaney

Touch Medical Media

Dr. O'Shaughnessy on Precision Medicine in Triple Negative Breast Cancer